Startseite>>Infectious Disease>> Bacterial Diseases>>Nitrocefin

Nitrocefin (Synonyms: Nitrocephin)

Katalog-Nr.GC14823

Nitrocefin ist ein chromogenes β-Lactamase-Substrat, das einen deutlichen Farbwechsel von gelb nach rot erfÄhrt, wenn die Amidbindung im β-Lactam-Ring durch β-Lactamase hydrolysiert wird.

Products are for research use only. Not for human use. We do not sell to patients.

Nitrocefin Chemische Struktur

Cas No.: 41906-86-9

Größe Preis Lagerbestand Menge
1mg
37,00 $
Auf Lager
5mg
66,00 $
Auf Lager
10mg
121,00 $
Auf Lager
25mg
272,00 $
Auf Lager
500mg
3.801,00 $
Auf Lager
1g
6.081,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Nitrocefin is a chromogenic cephalosporin substrate which is used for detection of β-lactamases. β-lactamases are enzymes produced by various microbes that mediate resistance to β-lactam antibiotics such as penicillins and  cephamycins. Comparing to other methods for β-lactamases detection, nitrocefin is more sensitive while using few materials and inexpensive equipment. The color change by nitrocefin can be followed quantitatively by measuring changes in absorption between 380 to 500 nm region[1].

Reference:
[1] O'Callaghan, Cynthia H et al.  Novel Method for Detection of B-Lactamases by Using a Chromogenic Cephalosporin Substrate. Antimicrobial Agents and Chemotherapy. 1972 Apr; 1(4):283-288.

Bewertungen

Review for Nitrocefin

Average Rating: 5 ★★★★★ (Based on Reviews and 3 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Nitrocefin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.